Ketamine for the treatment of depression.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Psychosocial Nursing and Mental Health Services

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3928/02793695-20121219-01PMID 23413455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single ketamine infusion in bipolar depression resistant to antidepressants: are neurotrophins involved?

  2013cited by this paper
• Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study

  2012cited by this paper
• Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

  2012cited by this paper
• Ketamine for depression: where do we go from here?

  2012cited by this paper
• Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.

  2011cited by this paper
• The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS.

  2011cited by this paper
• A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department.

  2011cited by this paper
• A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

  2010cited by this paper
• Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

  2010cited by this paper
• Rapid Antidepressant Effect of Ketamine Anesthesia During Electroconvulsive Therapy of Treatment-Resistant Depression: Comparing Ketamine and Propofol Anesthesia

  2010cited by this paper
• Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression.

  2009cited by this paper
• Ketamine : from medicine to misuse.

  2006cited by this paper
• A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

  2006cited by this paper
• Beyond Monoamines: Glutamatergic Function in Mood Disorders

  2005cited by this paper
• Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists.

  2000cited by this paper
• Antidepressant effects of ketamine in depressed patients.

  2000cited by this paper

• A Comparative Study on the Effectiveness of Electroconvulsive Therapy and Ketamine in Persons Suffering from Treatment-resistant Depressive Disorder

  2024cites this paper
• Ketamine Induces Lasting Antidepressant Effects by Modulating the NMDAR/CaMKII-Mediated Synaptic Plasticity of the Hippocampal Dentate Gyrus in Depressive Stroke Model

  2021cites this paper
• Blood transcriptional response to treatment-resistant depression during electroconvulsive therapy.

  2021cites this paper
• Factors Influencing Perceived Helpfulness and Participation in Innovative Research:A Pilot Study of Individuals with and without Mood Symptoms

  2021cites this paper
• Reviewing Treatments for Cocaine Consume Problems: The Gabapentinoid Alternative

  2021cites this paper
• Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

  2020cites this paper
• The next psychoactive drugs: From imipramine to ketamine

  2020cites this paper
• Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

  2020cites this paper
• Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome

  2020cites this paper
• Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives

  2020cites this paper
• Analgesic adjuvants modulate morphine-induced immune effects in mice

  2019cites this paper
• Pregnancy Depression from a Gender Perspective

  2019cites this paper
• Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review.

  2019cites this paper
• Rapid-acting antidepressants: shared neuropharmacological mechanisms

  2019cites this paper
• From gene networks to drugs: systems pharmacology approaches for AUD

  2018cites this paper
• Adrenergic and glucocorticoid receptor antagonists reduce ozone‐induced lung injury and inflammation

  2018cites this paper
• The glucocorticoid antagonist mifepristone attenuates sound‐induced long‐term deficits in auditory nerve response and central auditory processing in female rats

  2018cites this paper
• Neuronal nitric oxide synthase and affective disorders

  2018cites this paper
• Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.

  2018cites this paper
• Central Role of Glucocorticoid Receptors in Alzheimer’s Disease and Depression

  2018cites this paper
• The Role of Noncompetitive Antagonists of the N‐Methyl‐d‐aspartate (NMDA) Receptors in Treatment‐Resistant Depression

  2017cites this paper
• Back to the Future: Ketamine and Nitrous Oxide in Major Refractory Depression

  2017cites this paper
• Personalized medicine in psychiatry

  2017cites this paper
• The importance of the hypothalamo-pituitary-adrenal axis as a therapeutic target in anorexia nervosa.

  2017cites this paper
• Drug repurposing may generate novel approaches to treating depression

  2017cites this paper
• Clinical Management of Menopause-Related Sleep Disturbance

  2017cites this paper
• Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data

  2016cites this paper
• Ketamine improves survival in severe burn injury in rats via the expression of heat shock protein 70, far or close to the clinical perspective?

  2016cites this paper
• Using Oral and Intranasal Dosage Forms of Ketamine for Managing Treatment-Resistant Depression: A Review of the Literature

  2016cites this paper
• Effect of intraoperative application of ketamine on postoperative depressed mood in patients undergoing elective orthopedic surgery

  2016cites this paper
• Preclinical pharmacology and pharmacokinetics of CERC‐301, a GluN2B‐selective N‐methyl‐D‐aspartate receptor antagonist

  2015influential citation
• Quetiapine augmentation for depression: dosing pattern in routine practice

  2015cites this paper
• Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?

  2015cites this paper
• Comparison of the after discharges induced by electrical stimulation of the prefrontal cortex in urethane- and ketamine-anesthetized mice.

  2015cites this paper
• Comparing Gabapentin with Clonazepam for Residual Sleeping Problems following Antidepressant Therapy in Patients with Major Depressive Disorder: A Randomized Clinical Trial

  2015cites this paper
• Odds and ends in psychopharmacology from the past 10 years.

  2015cites this paper
• Emerging antidepressants to treat major depressive disorder.

  2014cites this paper
• The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

  2014cites this paper
• The multifaceted mineralocorticoid receptor.

  2014cites this paper
• Inflammation: a mechanism of depression?

  2014cites this paper
• Gabapentin: can it be misused?

  2014cites this paper
• Identifying rare variants for genetic risk through a combined pedigree and phenotype approach: application to suicide and asthma

  2014cites this paper
• Prenatal Antidepressant Exposure: Clinical and Preclinical Findings

  2014cites this paper
• The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test.

  2014cites this paper
• Gabapentin for Substance Use Disorders: Is it Safe and Appropriate?

  2014cites this paper
• Drugs currently in Phase II clinical trials for cocaine addiction

  2014cites this paper
• La alternativa de la ketamina

  2014cites this paper
• La ketamina mejora la supervivencia en ratas con quemaduras severas vía la expresión de la proteína de choque térmico 70, ¿cerca o lejos de la perspectiva clínica?

  2013cites this paper
• La ketamina mejora la supervivencia en ratas con quemaduras severas vía la expresión de la proteína de choque térmico 70, ¿cerca o lejos de la perspectiva clínica?

  2013cites this paper
• Ketamine improves survival in severe burn injury in rats via the expression of heat shock protein 70, far or close to the clinical perspective?

  2013cites this paper
• Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion.

  2013cites this paper
• Using measurement strategies to identify and monitor residual symptoms.

  2013cites this paper
• [Effects of ketamine and urethane on stimulation-induced c-fos expression in neurons of cat visual cortex].

  2013cites this paper
• Depression and clostridium difficile infection.

  2013cites this paper